Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Reliance (RS) Change in Accured Expenses (2016 - 2025)

Reliance (RS) has disclosed Change in Accured Expenses for 17 consecutive years, with -$146.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 77.79% to -$146.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.9 million, a 95.26% increase, with the full-year FY2025 number at -$6.9 million, up 95.26% from a year prior.
  • Change in Accured Expenses was -$146.5 million for Q4 2025 at Reliance, down from $13.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $217.9 million in Q1 2021 to a low of -$189.0 million in Q3 2022.
  • A 5-year average of -$12.6 million and a median of -$29.2 million in 2024 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: tumbled 1969.35% in 2021, then skyrocketed 2573.91% in 2025.
  • Reliance's Change in Accured Expenses stood at -$128.3 million in 2021, then increased by 26.97% to -$93.7 million in 2022, then soared by 41.84% to -$54.5 million in 2023, then plummeted by 51.19% to -$82.4 million in 2024, then crashed by 77.79% to -$146.5 million in 2025.
  • Per Business Quant, the three most recent readings for RS's Change in Accured Expenses are -$146.5 million (Q4 2025), $13.1 million (Q3 2025), and $12.7 million (Q2 2025).